FMP

FMP

Enter

HLVX - HilleVax, Inc.

photo-url-https://images.financialmodelingprep.com/symbol/HLVX.png

HilleVax, Inc.

HLVX

NASDAQ

HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.

1.86 USD

0.03 (1.61%)

HLVX Ratings

page loading card

Upgrades & Downgrades

We are unable to load this data!

fmp-logo

Price Targets

We are unable to load the data!

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep